PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis

dc.contributor.authorLester, S.
dc.contributor.authorHewitt, A.
dc.contributor.authorRuediger, C.
dc.contributor.authorBradbury, L.
dc.contributor.authorDe Smit, E.
dc.contributor.authorWiese, M.
dc.contributor.authorBlack, R.
dc.contributor.authorHarrison, A.
dc.contributor.authorJones, G.
dc.contributor.authorLittlejohn, G.
dc.contributor.authorMerriman, T.
dc.contributor.authorShenstone, B.
dc.contributor.authorSmith, M.
dc.contributor.authorRischmueller, M.
dc.contributor.authorBrown, M.
dc.contributor.authorHill, C.
dc.date.issued2016
dc.descriptionPublished online 7 April 2016.
dc.description.abstractGiant cell arteritis (GCA) is one of the commonest forms of vasculitis in the elderly, and may result in blindness and stroke. The pathogenesis of GCA is not understood, although environmental, infectious and genetic risk factors are implicated. One gene of interest is PTPN22, encoding lymphoid protein tyrosine phosphatase (Lyp), expressed exclusively in immune cells, which is proposed to be an 'archetypal non-HLA autoimmunity gene'. The minor allele of a functional PTPN22 single nucleotide polymorphism (rs2476601, R620W), which disrupts an interaction motif in the protein, was originally reported to be associated with biopsy-proven GCA in Spanish patients, with supporting data from three replicate Northern European studies. Recently, this observation was extended with additional patients and controls, and studies encompassing European, Scandinavian, UK and American patients. The aim of our study was to determine the association between PTPN22 rs2476601 (R620W) and biopsy-proven GCA in an Australian case cohort.
dc.description.statementofresponsibilitySusan Lester, Alex W Hewitt, Carlee D Ruediger, Linda Bradbury, Elisabeth De Smit, Michael D Wiese, Rachel Black, Andrew Harrison, Graeme Jones, Geoffrey O Littlejohn, Tony R Merriman, Bain Shenstone, Malcolm D Smith, Maureen Rischmueller, Matthew A Brown, Catherine L Hill
dc.identifier.citationRMD Open, 2016; 2(1):e000246-1-e000246-3
dc.identifier.doi10.1136/rmdopen-2016-000246
dc.identifier.issn2056-5933
dc.identifier.issn2056-5933
dc.identifier.orcidLester, S. [0000-0003-3013-2701]
dc.identifier.orcidRuediger, C. [0000-0002-0026-9873]
dc.identifier.orcidBlack, R. [0000-0001-6600-7430]
dc.identifier.orcidRischmueller, M. [0000-0001-5057-3286]
dc.identifier.orcidHill, C. [0000-0001-8289-4922]
dc.identifier.urihttp://hdl.handle.net/2440/106814
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1068023
dc.rightsPublished by the BMJ Publishing Group Limited. Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http:// creativecommons.org/licenses/by-nc/4.0/
dc.source.urihttp://dx.doi.org/10.1136/rmdopen-2016-000246
dc.subjectGene Polymorphism
dc.titlePTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_106814.pdf
Size:
517.26 KB
Format:
Adobe Portable Document Format
Description:
Published Version